三维适形放疗联合NP方案同期化疗治疗Ⅲ期非小细胞肺癌分析  被引量:6

Three Dimensional Conformal Radiotherapy Combined with Chemotherapy NP for Ⅲ Stage Non-Small Cell Lung Cancer

在线阅读下载全文

作  者:张彬[1] 韩春[2] 王澜[2] 

机构地区:[1]复旦大学附属金山医院放疗科,上海200540 [2]河北医科大学第四医院放疗科,河北石家庄050011

出  处:《中国临床医学》2010年第3期373-375,共3页Chinese Journal of Clinical Medicine

摘  要:目的:观察三维适形放疗联合NP方案同期化疗治疗局部Ⅲ期非小细胞肺癌的不良反应与临床疗效。方法:37例Ⅲ期非小细胞肺癌患者接受三维适形放疗及同期化疗。观察患者的治疗完成情况,治疗期间、治疗后的不良反应及近期疗效。结果:全组患者白细胞减少发生率为91.9%。急性肝肾损伤发生率为13.5%(5/37)。急性放射性食管炎0级3例,1级11例,2级9例,3级14例。急性放射性肺炎0级2例,1级15例,2级12例,3级8例。治疗结束后完全缓解(CR)3例,部分缓解(PR)32例,稳定(SD)2例,总有效率(PR+CR)为94.6%(35/37)。1年局部控制率为83.4%,1年生存率为75.8%,中位生存期15个月。结论:三维适形放疗联合同期化疗治疗局部Ⅲ期非小细胞肺癌可取得较好的近期疗效;不良反应较重,但可耐受。Objective:To evaluate the acute side effects and efficacy of three dimensional conformal radiotherapy(3DCRT) combined with concurrent chemotherapy for stage III non small cell lung cancer(NSCLC).Methods: From Sep.2006 to June.2008,37 patients with NSCLC were treated with 3D-CRT combined with concurrent chemotherapy of navelbine and cisplatin(NP).The side effects and clinical results were observed.Results: The leucocytopenia rate was 91.9%,35 patients developed radiation pneumonitis(RP): 15 grade 1,12 grade 2 and 8 grade 3,there was no radiation pneumonitis of grade 4.The acute radiation esophagitis were: 3 grade 0,11 grade 1,9 grade 2 and 14 grade 3.There were 3 patients(8.1%) received complete remission(CR),32 patients(86.5%) received partial remission(PR),the overall response rate was 94.6%(CR+PR).The 1-year local control rate was 83.4%,the 1-year overall survival rate was 75.8%.The median survival time was 15 months.Conclusions: 3DCRT combined with concurrent chemotherapy of NP has good short-term results on NSCLC,the side effects are obvious but could be tolerated to most patients,long term results need further observation.

关 键 词:非小细胞肺癌 三维适形放射治疗 化学疗法 预后 

分 类 号:R734.2[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象